Cuba Culture

Cuban drug Heberpenta may be exported next year

Posted January 07, 2008 by publisher in Cuba Culture.

Cuba’s pharmaceutical industry is working to expand its presence on the international market by commercializing new medicines.

Among the new medicines that might be exported during the 2008-2010 period is the pentavalent vaccine Heberpenta, which immunizes against diphtheria, tetanus, whooping cough, hepatitis B and the bacteria Haemophilus influenzae type B.

Heberpenta is produced by the company Heber Biotec S.A., which is the exclusive representative of the Genetic Engineering and Biotechnology Center and other Cuban scientific institutions.

The Cuban company will also export interferon gel to treat cervical-uterine cancer, and recombinant streptokinase (Heberkinasa), which destroys blood clots.

It also plans to commercialize a viscous solution containing Skin Growth Factor (Hebervis), which speeds up the regeneration of mucus and minimizes the secondary effects of radiotherapy treatments.

Member Comments

On August 06, 2008, Neida Manzano wrote:

esa vacuna trae efectos colaterales previa a su colocacion, y no es la primera vacuna que exiaste de ese tipo el laboratorio glaxo elaboro una vacuna que se llama infarix Hexa que proteje contra seis enfermedades y no ninguna reaccion